文献速递头颈外科咽喉与嗓音

超越TNM:肿瘤体积作为喉癌预后标志物

Beyond TNM: Tumor Volume as a Prognostic Marker in Laryngeal Cancer.
PubMed 文献 · Laryngoscope · 2026-08-30

肿瘤体积阈值22.498 cm³与死亡率增加3.6倍相关,高体积组OS和DFS均显著更差,多变量分析中高体积仍独立与OS相关(HR=9.66)。肿瘤体积可能改善TNM分期之外的风险分层。

要点

  • 肿瘤体积阈值22.498 cm³可识别喉鳞癌高危亚组,与更差OS和DFS显著相关
  • 多变量分析中高肿瘤体积独立与OS相关(HR=9.66,95%CI 2.56-36.39)
  • 肿瘤体积与T分期和淋巴结阳性相关,声门上型和跨声门型体积更大

核心结论

  • 肿瘤体积独立与喉鳞状细胞癌的生存结局相关,可能改善单纯TNM分类之外的风险分层。
  • 阈值22.498 cm³可识别高危亚组,需前瞻性验证以整合入分期和治疗计划。

研究设计与样本

  • 肿瘤体积来自CT、MRI或放疗计划轮廓,作为连续和二元变量分析,阈值由log-rank最大化确定。
  • 生存分析采用Kaplan-Meier法和Cox比例风险模型。

主要发现

  • 中位肿瘤体积3.7 cm³(范围0.03-51.3 cm³)。
  • 体积阈值22.498 cm³与死亡率增加3.6倍相关(60.0% vs 16.7%;p<0.001),高体积组OS和DFS均显著更差(均p<0.001)。
  • 多变量分析中,调整年龄、T分期和淋巴结状态后,高肿瘤体积仍独立与OS相关(HR=9.66,95%CI:2.56-36.39)。
  • 肿瘤体积与T分期相关(Spearman ρ=0.569,p<0.001),淋巴结阳性肿瘤大于淋巴结阴性肿瘤(中位5.6 cm³ vs 2.6 cm³;p=0.017)。
  • 声门上型和跨声门型肿瘤体积大于声门型,高级别肿瘤与更大体积相关;非手术患者肿瘤小于手术患者。

关键数值与推荐

  • 肿瘤体积阈值22.498 cm³为log-rank最大化确定的高危界值,与死亡率增加3.6倍相关。

临床怎么用

  • 在喉鳞癌风险分层中可考虑纳入影像学肿瘤体积,尤其阈值22.498 cm³以上者提示高危。
  • 肿瘤体积可与TNM分期结合用于治疗计划和预后沟通,但需前瞻性验证后常规整合。

局限性

  • 肿瘤体积来源包括CT、MRI或放疗计划轮廓,测量方法异质性可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this study is to determine whether radiologic tumor volume adds prognostic value for overall survival (OS) and disease-free survival (DFS) in laryngeal squamous cell carcinoma (LSCC) and to evaluate associations with T stage, nodal status, histologic grade, subsite, and treatment modality. METHODS: Patients with cT2-T4 LSCC treated with curative intent between 2018 and 2024 were included. Tumor volumes derived from CT, MRI, or radiotherapy planning contours were analyzed as continuous and binary variables using a threshold identified by log-rank maximization. Survival was assessed with Kaplan-Meier methods and Cox proportional hazards models. RESULTS: Eighty-eight patients were included (39.8% surgical and 60.2% nonsurgical). Median tumor volume was 3.7 cm3 (range 0.03-51.3 cm3). Volume threshold of 22.498 cm3 was associated with a 3.6-fold increase in mortality (60.0% vs. 16.7%; p < 0.001), with significantly worse OS and DFS in the high-volume group (both p < 0.001). On multivariable analysis, high tumor volume remained independently associated with OS after adjustment for age, T stage, and nodal status (HR = 9.66, 95% CI: 2.56-36.39). Tumor volume correlated with T stage (Spearman ρ = 0.569, p < 0.001), and node-positive tumors were larger than node-negative tumors (median 5.6 cm3 vs. 2.6 cm3; p = 0.017). Supraglottic and transglottic tumors had larger volumes than glottic and higher-grade tumors were associated with larger volumes. Nonsurgical patients had smaller tumors than surgical patients. CONCLUSION: Tumor volume was independently associated with survival outcomes in LSCC and may improve risk stratification beyond TNM classification alone. A threshold of 22.498 cm3 identifies a high-risk subgroup and warrants prospective validation for integration into staging and treatment planning.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Uralov D, Iovine C, Di Cristina L, et al. Beyond TNM: Tumor Volume as a Prognostic Marker in Laryngeal Cancer. Laryngoscope. 2026. PMID: 42669883. doi:10.1002/lary.70879

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。